Sale of Productive Assets, Consideration Received, Equity Interests Issued and Issuable

No definition available.

Name:	isee_SaleOfProductiveAssetsConsiderationReceivedEquityInterestsIssuedAndIssuable
Namespace Prefix:	isee_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	duration

- Definition

Sale of Productive Assets, Consideration Received, Equity Interests Issued and Issuable, Fair Value

+ References

No definition available.

+ Details

Name:	isee_SaleOfProductiveAssetsConsiderationReceivedEquityInterestsIssuedAndIssuableFairValue
Namespace Prefix:	isee_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Sale of Productive Assets, Consideration Received, Equity Interests Issued and Issuable, Par Value

+ References

No definition available.

+ Details

Name:	isee_SaleOfProductiveAssetsConsiderationReceivedEquityInterestsIssuedAndIssuableParValue
Namespace Prefix:	isee_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

Sale of Productive Assets, Contingent Consideration Arrangements, Range of Outcomes, Value, High

+ References

No definition available.

+ Details

Name:	isee_SaleOfProductiveAssetsContingentConsiderationArrangementsRangeOfOutcomesValueHigh
Namespace Prefix:	isee_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The cash inflow from the sale of property, plant and equipment (capital expenditures), software, and other intangible assets.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 12
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585

+ Details

Name:	us-gaap_ProceedsFromSaleOfProductiveAssets
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

- Details

Name:	srt_CounterpartyNameAxis=isee_OpusGeneticsIncMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ContingentConsiderationByTypeAxis=isee_ContingentDevelopmentAndRegulatoryMilestonePaymentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_ContingentConsiderationByTypeAxis=isee_AdditionalSalesMilestonePaymentsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_StatementClassOfStockAxis=isee_SeriesSeedPreferredStockMemberMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Fair Value Measurements - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Fair Value Measurements
Proceeds from sale of assets		$ 500	$ 0	$ 0
Purchase agreement fair value of shares, recognized		$ 1,869	$ 0	$ 0
Opus Genetics Inc
Fair Value Measurements
Proceeds from sale of assets	$ 500
Opus Genetics Inc \| Significant unobservable inputs (Level 3)
Fair Value Measurements
Purchase agreement fair value of shares, recognized	1,900
Opus Genetics Inc \| Contingent Development And Regulatory Milestone Payments
Fair Value Measurements
Contingent development and regulatory milestone amount	12,800
Opus Genetics Inc \| Sales Milestone Payments
Fair Value Measurements
Contingent development and regulatory milestone amount	$ 98,900
Series Seed Preferred Stock \| Opus Genetics Inc
Fair Value Measurements
Purchase agreement consideration (in shares)	2,632,720
Purchase agreement consideration (in us dollar per share)	$ 0.00001